According to Cancer Research UK, cases of melanoma skin cancer in the UK have reached an unprecedented level, with an estimated 20,800 individuals expected to receive a diagnosis this year. Over the past decade, rates of melanoma have surged by nearly a third, rising from 21 to 28 cases per 100,000 people between 2007-2009 and 2017-2019. Notably, this upward trend is evident across all age groups, with the most significant increase observed among adults over 80, marking a 57% rise in cases over the past decade. Additionally, there has been a 7% increase in cases among individuals aged 25 to 49.
Experts attribute a substantial portion of melanoma cases to excessive exposure to ultraviolet (UV) radiation, primarily from the sun or sunbeds, which can damage DNA in skin cells and trigger cancerous growths. To mitigate risk, Cancer Research UK advises individuals to adopt sun-safe practices such as seeking shade during peak UV hours, wearing protective clothing and accessories, and applying sunscreen with adequate sun protection factor (SPF) regularly.
Caroline Jones, a postmistress from Shrewsbury, shares her harrowing experience of being diagnosed with skin cancer after noticing a peculiar blemish on her leg. Her advocacy underscores the importance of proactive skin monitoring and seeking medical attention for any concerning changes.
While the incidence of melanoma continues to rise, advancements in early detection and treatment have contributed to improved survival rates. According to Cancer Research UK, nearly nine in 10 adults diagnosed with melanoma in England are expected to survive their disease for a decade or more. Nevertheless, early detection remains paramount, emphasizing the significance of promptly reporting any suspicious skin alterations to healthcare providers.
Factors contributing to the escalating cases of melanoma include a burgeoning and ageing population, heightened awareness of skin cancer symptoms, and historical sun exposure patterns, particularly prevalent among individuals who availed themselves of budget travel options since the 1960s.
Innovations in cancer therapeutics offer promising avenues for combating melanoma, as evidenced by ongoing trials of personalized mRNA vaccines tailored to individual patients. These groundbreaking interventions hold the potential to revolutionize cancer treatment, offering hope for improved outcomes and eventual eradication of the disease.
